Real World Canadian Case Series: Use of Tildrakizumab for Moderate to Severe Psoriasis Biologic and Small Molecule Therapies for Moderate to Severe Psoriasis: Focus on Psoriasis Comorbidities BioDrugs Springer Nature Link Frontiers Interventions in cytokine signaling: novel horizons for psoriasis treatment Apremilast in the therapy of moderate to severe chronic plaque psorias DDDT Dove Medical Press Psoriasis: A Review of Diagnosis and Treatment in the Primary Care Setting Consultant360 Oral Peptides: FAQs on Bioavailability, Safety, and Clinical Use AJMC